Epiontis ID: Use Cases Across Diverse Therapeutic Areas

Measuring how a therapy changes the immune system is central to many clinical trials. Traditional methods like flow cytometry often require fresh samples, rapid on-site processing, and large blood draws, and those hurdles get harder in multisite, pediatric, or low-resource studies. Discover how Epiontis ID uses epigenetic markers, which are chemical tags on DNA that identify specific cell types, to count more than 35 immune cell populations. It works with whole blood, tissue, dried blood spots, and even nasal swabs, and samples can ship at room temperature or frozen in batches.

Drawing on published studies, the piece walks through real-world uses across autoimmune disease, oncology, infectious disease, sepsis, pediatrics, and cell therapy. Explore these examples to see how you can simplify sample logistics and get consistent, comparable immune data at every stage of your trial.